(Q30436323)

21 June 2017

Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model (English)

1 reference

21 June 2017

0 references

influenza A virus

1 reference

3

Frederick G Hayden

1 reference

21 June 2017

4

Larisa V Gubareva

1 reference

21 June 2017

1

Vasiliy P Mishin

1 reference

21 June 2017

Marina S Nedyalkova

2

1 reference

PubMed ID

15780741

21 June 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

21 June 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 June 2017

23

1 reference

21 June 2017

22

1 reference

21 June 2017

2922-2927

1 reference

Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Development and characterization of cold-adapted viruses for use as live virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

A novel mechanism for the acquisition of virulence by a human influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Role of neuraminidase in influenza virus-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Mucins and mucoids in relation to influenza virus action; general discussion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Resistance of influenza viruses to neuraminidase inhibitors--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Evaluation of a cold-recombinant influenza virus vaccine in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

A DNA transfection system for generation of influenza A virus from eight plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Intercontinental Circulation of Human Influenza A(H1N2) Reassortant Viruses during the 2001–2002 Influenza Season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

inferred from DOI database lookup

7 January 2021

based on heuristic

Influenza virus neuraminidase activates latent transforming growth factor beta.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.058

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.058

1 reference

21 June 2017

1 reference

PubMed ID

15780741